WASHINGTON, Oct. 16 -- The Centers for Medicare & Medicaid Services issued the following press release:
Background
On Oct. 16, 2026, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule to implement key sections of the Consolidated Appropriations Act of 2026 including section 6220 (Requiring Enhanced and Accurate Lists of (REAL) Health Providers Act) and section 6224 (Modernizing and Ensuring Pharmacy Benefit Manager Accountability). This rule also proposes a conforming change mandated by section 6219 of the CAA (Adjustments to Medicare Part D Cost-Sharing Reductions for Low-Income Individuals) that would reduce the generic drug copayment from $1 to $0 for full-benefit dual eligible individuals.
Implementing Certain...